With the microbiome market set to expand to more than $ 1 billion in the coming years, contract manufacturers across the board are putting big down payments on capacity for live therapies that target gut bacteria. Now, a fledgling CDMO is splurging to make its name in that blossoming field. Microbiome CDMO firm Arranta Bio has completed… Read More »
Disclosure: This article may contain affiliate links, meaning I may get a commission if you make a purchase through my links, at no extra cost to you. One of the most delicious and versatile members of the meat pantheon is pork. From bacon, to pork chops, this meat offers many variations that can be worked… Read More »
They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in, or filling in forms. The Clue website uses third-party analysis and tracking services to track the performance of our services, understand how you use our services, and offer… Read More »
You’ve heard the one about three characters walking into a bar. A new collaboration between United Airlines, Cleveland Clinic and Clorox reminded me of that scenario, and that in the age of the coronavirus pandemic, collaboration can bolster our health. In the era of COVID-19, people — consumers. patients managing chronic conditions, and caregivers (whether… Read More »
As Biogen preps for its closely watched aducanumab FDA filing in Alzheimer’s disease, a patent threat for the company’s top-selling medicine is causing concern for one team of analysts. In a note to clients Tuesday, Bernstein analyst Ronny Gal and his team downgraded Biogen’s stock—from outperform to market-perform—based on the belief that Mylan will win… Read More »